Why Iovance Stock Leaped 17% Higher Today
Investors often get excited when top officials at a company pile into shares of their business. So it was on Friday with Iovance Biotherapeutics (NASDAQ: IOVA). A flurry of insider buying led to plenty of outsider buying on the market, and pushed the stock's price 17% higher on the day.
As revealed by Securities and Exchange Commission filings dated Thursday, everyone who is anyone at Iovance, it seems, was hitting the buy button.
Image source: Getty Images.
Source Fool.com
